OGEN vs TECH
Oragenics Inc (OGEN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
OGEN currently screens at market cap $2.7M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the OGEN and TECH stock pages for the full models.
Not investment advice.